Product
NKG2D CAR-NK
3 clinical trials
3 indications
Indication
Metastatic Colorectal CancerIndication
Ovarian CancerIndication
acute myeloid leukemiaClinical trial
NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal CancerStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
NKG2D CAR-NK Cell Therapy for Patients With Platinum-Resistant Recurrent Ovarian CancerStatus: Recruiting, Estimated PCD: 2024-04-01
Clinical trial
NKG2D CAR-NK Cell Therapy for the Treatment of Patients With Relapsed and/or Refractory Acute Myeloid LeukemiaStatus: Recruiting, Estimated PCD: 2024-04-01